Inve India ▾
PIPIDILITIND

Pidilite Industries Q3 FY26 results (Oct–Dec 2025) and concall

Chemicals · Concall AI · Call held 4 Feb 2026

Pidilite delivered a strong Q3 FY26 with domestic franchise continuing to strengthen (11% domestic UVG). Exports were the main drag, declining 13.5% due to US tariff impacts on pigments and indirect B2B exposure. Management is confident this is largely behind them. Gross margin tailwinds from benign VAM prices were partially offset by a one-time Wage Code provision. The company continues to invest behind brands (stepped up A&SP) while maintaining margins at the upper end of their 20-24% EBITDA corridor. Construction portfolio shows no slowdown with Dr. Fixit regaining market share and Roff/til

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q3 FY26: revenue up 10.1%, net profit up 12.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue3,235 3,369 3,141 3,753 3,554 +10%3,710 +10%
EBITDA768 798 632 941 850 +11%894 +12%
Net profit540 557 428 678 585 +8%624 +12%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.